Menu

Monoclonal Antibodies


More Treatment Topics

Chemotherapy | Immunotherapy | Radiotherapy | Treatment

Monoclonal Antibodies
Zevalin
Monoclonal Antibodies
Bioscan Requirement Lifted for Zevalin Treatment

FDA Approves the Removal of the Bioscan Requirement for ZEVALIN® Treatment

HENDERSON,

Monoclonal Antibodies
New antibody giving Rituxan a run for the money?

Rituxan (rituximab), the anti-CD20 monoclonal antibody from Roche, has carried the market since

Monoclonal Antibodies
Monoclonal Antibody Therapy: Rituxan

Rituxan® is the brand marketing name of the monoclonal

Monoclonal Antibodies
Rituximab Patients Need to be Screened for Hepatitis B Virus

According to research presented at the annual meeting of the American Society of Hematology,

Monoclonal Antibodies
Zevalin hits high notes at 2011 Lymphoma Conference

The 11th International Conference on Malignant Lymphoma

Monoclonal Antibodies
Darzalex Becomes First Monoclonal Antibody for Multiple Myeloma

Today the US Food and Drug Administration granted accelerated approval for Darzalex (

Monoclonal Antibodies
Rituxan effective against more than just lymphoma

The monoclonal antibody Rituxan (rituximab),

Monoclonal Antibodies
Studies demonstrate BEXXAR's efficacy against indolent lymphomas

The results of a pair of long-term survival studies indicate the therapeutic value of

Monoclonal Antibodies
Is Your Doctor on the Rituxan Retirement Plan?

In case you're unfamiliar, the Rituxan Retirement Plan (RRP) is an inside joke amongst

Monoclonal Antibodies
Radiolabeled Monoclonal Antibody Therapy: Bexxar®

Bexxar® (tositumomab and iodine I 131 ) is a radiolabled

Monoclonal Antibodies
Monoclonal Antibody Therapy

Monoclonal Antibody (mAB) Therapy is a type of

Monoclonal Antibodies
Monoclonal Antibody Therapy: Oncolym

Oncolym (131I Lym-1) is an Iodine 131 radiolabled

Monoclonal Antibodies
Spectrum makes deeper commitment to Zevalin

Spectrum Pharmaceuticals has announced that it intends to acquire the international

Monoclonal Antibodies
Zevalin plus BEAM beats BEAM alone in ASCT

Spectrum Pharmaceuticals is reporting results from a randomized study pitting the company's

Click for More Articles...